Ping Jin

Ping Jin is an accomplished scientist with extensive experience in drug development and immuno-oncology. Currently serving as Associate Director and Bioassay Group Lead at Arrowhead Pharmaceuticals since May 2020, Ping previously held the position of Senior Scientist at Viscient Biosciences, specializing in 3D tissue culture systems and NASH drug development. Prior roles include Staff Scientist in Oncology at Takeda Pharmaceuticals, where significant work involved identifying oncology ADC targets, and Senior Scientist at Pfizer's CovX Research Unit, contributing to early-stage drug discovery for metabolic disorders. With an educational background in Molecular Genetics from Iowa State University, Ping has demonstrated expertise in assay development, target identification, and translational pharmacology across various biotech and pharmaceutical companies.